BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 9002750)

  • 1. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
    Fischer M
    Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide therapy of pheochromocytomas and neuroblastomas using iodine-131 metaiodobenzylguanidine (MIBG).
    Brendel AJ; Jeandot R; Guyot M; Lambert B; Drouillard J
    Clin Nucl Med; 1989 Jan; 14(1):19-21. PubMed ID: 2714036
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 8. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
    Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
    Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete remission of metastatic pheochromocytoma in
    Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
    BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
    Nakabeppu Y; Nakajo M
    Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
    Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
    Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].
    Horne T
    Harefuah; 1992 Apr; 122(8):526-9. PubMed ID: 1398325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.